AKT1 and melanoma: Although NECTIN4 is known to regulate the PI3K/Akt pathway in several cancers, such as breast, gastric, thyroid, and melanoma [32,37,38,39], this pathway was not affected by NECTIN4 inhibition under the present experimental conditions.